Skip to main content
LIFECOME BIOCHEMISTRY CO., LTD. logo

LIFECOME BIOCHEMISTRY CO., LTD. — Investor Relations & Filings

Ticker · 002868 ISIN · CNE100002QH2 LEI · 65560089EP03NANEN790 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,742 across all filing types
Latest filing 2024-04-29 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002868

About LIFECOME BIOCHEMISTRY CO., LTD.

https://www.pclifecome.com

Lifecome Biochemistry Co., Ltd. focuses on the research, development, and large-scale production of fermentation-based veterinary pharmaceuticals and feed additives. The company’s core product portfolio includes Bacitracin Zinc, Bacitracin Methylene Disalicylate (BMD), and Colistin Sulfate, available in both active pharmaceutical ingredient (API) and premix forms. These biochemical products are primarily utilized in the livestock and poultry sectors to manage enteric health and improve feed efficiency. The organization operates advanced fermentation and purification facilities, maintaining compliance with international Good Manufacturing Practices (GMP) and various global regulatory standards. By leveraging specialized biotechnological processes, the company provides high-purity solutions aimed at enhancing animal nutrition and disease prevention across international markets.

Recent filings

Filing Released Lang Actions
董事会对独立董事独立性评估的专项意见
Governance Information Classification · 95% confidence The document is a special report from the board of directors regarding the independence of the company's independent directors. It references regulatory requirements from the China Securities Regulatory Commission and Shenzhen Stock Exchange rules about independent directors' independence. The content focuses on the evaluation and confirmation of the independent status of certain directors, which is a governance-related matter. The document is short (486 characters) and does not contain financial data or detailed financial performance. It is not an announcement of voting results, nor a certification letter. It fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2024-04-29 Chinese
立信会计师事务所（特殊普通合伙）关于绿康生化股份有限公司2023年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an "审计报告及财务报表" (Audit Report and Financial Statements) for the fiscal year 2023, covering the period from January 1, 2023, to December 31, 2023. It includes an audit opinion, detailed audit procedures, key audit matters, and comprehensive financial statements such as consolidated and parent company balance sheets, profit and loss statements, and cash flow statements. The presence of an audit opinion and detailed financial data indicates this is a standalone audit report rather than a full annual report or a brief announcement. The document length is substantial (15,000 characters), and it contains actual financial data and analysis, not just a reference or announcement. Therefore, the document fits the category of an Audit Report / Information (AR). FY 2023
2024-04-29 Chinese
公司2024年度董事、监事薪酬方案
Remuneration Information Classification · 95% confidence The document is titled '2024 年董事、监事薪酬方案' which translates to '2024 Directors and Supervisors Remuneration Plan'. It details the remuneration standards, principles, and payment methods for the company's board members and supervisors for the year 2024. It references relevant laws and governance codes but does not contain financial statements or performance data. The content is focused on compensation policies for executives and directors, which aligns with the definition of Remuneration Information filings. The document length is 1333 characters, indicating it is a detailed policy document rather than a brief announcement or a full annual report. Therefore, the appropriate classification is Remuneration Information (DEF 14A).
2024-04-29 Chinese
上市公司独立董事提名人声明与承诺（赵克辉）
Board/Management Information Classification · 95% confidence The document is a formal statement and commitment by a nominator regarding the nomination of an independent director candidate for the company's board. It includes detailed declarations about the candidate's qualifications, compliance with relevant laws and regulations, and independence criteria. There are no financial statements, earnings data, or report summaries. The content is focused on board/management information, specifically about the nomination of a board member. This fits the category of Board/Management Information (MANG). The document length is about 5,000 characters, which is consistent with a detailed announcement rather than a full report or a brief notice.
2024-04-29 Chinese
关于参加独立董事培训并取得独立董事资格证书的承诺函（吕虹）
Board/Management Information Classification · 95% confidence The document is a commitment letter from a nominated independent director candidate agreeing to attend training and obtain a qualification certificate recognized by the Shenzhen Stock Exchange. It is a personal declaration related to board membership qualifications, not a report, announcement of voting results, or financial disclosure. It pertains to board/management information regarding director qualifications and commitments. Therefore, it fits best under Board/Management Information (MANG). The document is very short and does not contain financial data or meeting results, so other categories are not appropriate.
2024-04-29 Chinese
审计委员会关于2023年度审计机构履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is a report from the Audit Committee of the Board of Directors regarding the supervision of the audit firm for the fiscal year 2023. It details the appointment process, qualifications, and performance of the audit firm (Lixin CPA firm) in auditing the company's 2023 financial statements. The document includes the committee's evaluation of the audit firm's independence, professionalism, and the audit process, culminating in the issuance of an unqualified audit report. The content focuses on the audit report and the committee's oversight role rather than the full annual report itself. The document length is 1860 characters, which is relatively short but contains substantive information about the audit process and results, not merely an announcement or certification. Therefore, it fits the definition of an Audit Report / Information (AR) rather than an Annual Report (10-K) or a Regulatory Filing (RNS). FY 2023
2024-04-29 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.